A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer

Summary

This trial investigates pemetrexed and cisplatin followed by pemetrexed and cisplatin in combination with radiotherapy in participants with locally advanced, non-small cell lung cancer (NSCLC). The purpose of the study is to assess the antitumor activity as measured by progression free survival 1 year after start of treatment with study drug.

Timeline

Start

2009-10

Primary completion

2013-01

Completion

2013-07

Outcome

Missed primary endpoint

registry p = 0.0645; maximum likelihood estimate; note: P-value for H0 which compared the investigational regimen to historical data. NCT01000480 ↗

Drugs

Indications